Asembia's AXS25 Summit welcomed thousands of specialty pharmacy and industry attendees from April 27 – May 1, further establishing its role as a convener of healthcare leaders and decision-makers focused on improving...

Amgen (NASDAQ:AMGN) will present at the Bank of America Merrill Lynch Global Healthcare Conference at 9:20 a.m. PT on Wednesday, May 14, 2025. Peter Griffith, executive vice president and chief financial officer at Amgen,...

American Liver Foundation (ALF) is excited to announce today the 2025 winners of their Liver Health Poster Competition. This competition showcases posters and a brief video created by early career healthcare professionals...

U.S. prescription drug expenditures rose to $805.9 billion in 2024 - an increase of 10.2% over the previous year - fueled in large part by soaring demand for weight-loss drugs, known as GLP-1 receptor agonists, according...

WESTON, Fla., May 9, 2025 /PRNewswire/ - Apotex Corp. today launched IVRA™ (Melphalan) hydrochloride injection 90mg/ml multidose vial ("IVRA"), first ready-to-dilute liquid formulation of Melphalan injection approved via...

Skin Clique, the physician-founded aesthetics company transforming access to medically backed skincare in 42 states, announced the launch of its Esthetician Program-a new offering that delivers personalized, virtual...

Target RWE, a leader in modern clinical evidence generation for complex diseases, today announced its presentations and strategic contributions at the EASL Congress 2025 in Amsterdam, Netherlands. Target RWE unveiled...

DOMA Perpetual Capital Management LLC, a significant stockholder of InMode Ltd. (NYSE: INMD) ("InMode"), today sent a letter to the Board of Directors of InMode (the "Board") urging the Board to continue its stock...

Eli Lilly and Company (NYSE: LLY) and Purdue University announced today a significant expansion of their long-standing alliance, with Lilly's planned investment of up to $250 million in the collaboration over the next...

Palatin Technologies, Inc. (OTC PINK: PTNT), a biopharmaceutical company advancing innovative treatments targeting the melanocortin receptor system, today announced new preclinical data on its melanocortin agonists PL9654...

SystImmune, Inc. (SystImmune), a clinical-stage biotechnology company, today announced that one abstract on izalontamab brengitecan (iza-bren), a potentially first-in-class EGFRxHER3 bispecific antibody drug conjugate...

With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help healthcare journalists and consumers stay on top of the month's most popular releases and...

Minghui Pharmaceutical ("Minghui"), a late-stage clinical biopharmaceutical company, today announced an exclusive licensing and collaboration agreement with Qilu Pharmaceutical ("Qilu") for the development, manufacturing,...

What if a protein could emulsify-without a single additive?

Envision Energy, a global leader in green technology,  released its 2025 Net Zero Action Report at the Smarter E Europe in Munich, reaffirming its commitment to climate leadership. The company achieved operational carbon...

Spyre Therapeutics, Inc. ("Spyre" or the "Company") (NASDAQ:SYRE), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, dose optimization, and rational therapeutic combinations to target...

The Sarcoma Alliance for Research through Collaboration (SARC) is proud to announce the re-launch of a significantly enhanced SARC Sarcoma Centers Directory (SCD, https://sarctrials.org/sarcoma-centers). The SCD serves as...

The year 2025 marks a historic milestone for Critical Path Institute® (C-Path), as the organization celebrates 20 years of transforming the landscape of drug development through collaboration, regulatory science, and...

TimelyCare, higher education's most trusted virtual health and well-being provider, has once again secured its place among the world's top health tech companies.

With deaths by overdose exceeding 107,000 each year, one in four teens dealing with addiction, and a $6 trillion global mental health crisis looming, STAR Network™ – in partnership with Caron Treatment Centers – is...

EASWE, a forward-thinking mobility solutions company, is proud to introduce its latest innovations: the A10 and B10 electric wheelchairs. These two models are purposefully engineered to help seniors and individuals with...

Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), and Optieum Biotechnologies (Optieum), a preclinical stage company dedicated to the discovery and development of...

Zenni Optical, the world's leading online eyewear retailer, announced the launch of the "I Run For…" campaign, led by long-time brand ambassador Chase Stokes. Timed to Mental Health Awareness Month and created in...

Careington International Corporation is proud to expand the product options available through its brand GetMore. Careington developed its proprietary prescription savings program to offer substantial savings on...

In recognition of Nurses Week, Medical Solutions is proud to celebrate the compassion, resilience, and clinical excellence of nurses across the country. As one of the nation's largest and most trusted healthcare...

Luminopia, Inc., a digital health company pioneering a new class of treatments for neuro-visual disorders, today announced that Anthem Blue Cross and Blue Shield has approved its amblyopia treatment for coverage. Patients...

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced that preclinical research exploring key mechanisms underlying amyotrophic lateral sclerosis (ALS) pathology will be presented at the 2025 ALS Drug Development...

Oracle Health Information Network Inc., a subsidiary of Oracle Health, is now a candidate Qualified Health Information Network® (QHIN™) as a part of the Trusted Exchange Framework and Common Agreement™ (TEFCA™). With this...

Capital Rx, Inc., the enterprise health technology company and benefit administrator advancing our nation's electronic healthcare infrastructure, today announced that Judi Health™ has been selected as the winner of the...

Lori Tierney Brings Vast Expertise and Experience to Help ACTO Lead the Life Sciences Industry Towards an AI-First Future

The Board of Trustees of ETF Series Solutions, upon a recommendation from Exchange Traded Concepts, LLC, the investment adviser to the Range Cancer Therapeutics ETF (the "Fund"), has determined to close and liquidate the...

Korman Plastic Surgery and Wunderbar MedSpa, founded and led by board-certified plastic surgeon Dr. Joshua Korman, has partnered with Cosmetic Physician Partners (CPP). This partnership supports Korman Plastic...

ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that it will host a conference call and live webcast on Wednesday, May 14,...

Company continues to explore and review strategic options focused on maximizing shareholder value

Cytoki Pharma ApS (Cytoki), a clinical-stage biotechnology company pioneering a new class of medicines that harness interleukin-22 (IL-22) biology to drive improved metabolic and other health outcomes, today announced the...

Eli Lilly and Company (NYSE: LLY) today announced executive leadership transitions that will further enhance the company's ability to drive sustained, long-term growth and ensure that its medicines continue to reach...

Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, today announced that Eric Matthews has joined the organization as Chief Business Officer, Biopharma Business...

Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering novel approaches to precision T cell activation, today announced that the first patient has been dosed in its STARt-002 clinical trial. The...

Haemonetics Corporation (NYSE: HAE) announced that financial results for its fourth quarter and fiscal year 2025, which ended March 29, 2025, are available on its Investor Relations website.

Hyundai Bioscience presented the results of its Penetrium™ combination preclinical studies at the 2025 American Association for Cancer Research (AACR) Annual Meeting, held in Chicago.

SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, today announced late-breaking clinical data from its Phase 1 trial...

Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK), a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet medical need, today announced...

The Family Heart Foundation, a leading research and advocacy organization focused on the role of lipids in cardiovascular disease and prevention, today announced results from the largest study ever conducted of people...

TiumBio (KRX: 321550.KQ), a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapeutics for patients with rare and incurable disease, today announced that Merigolix (code name:...

Dynavax Technologies Corporation (Nasdaq: DVAX) ("Dynavax" or the "Company"), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today issued the following statement in...

Montrose Environmental Group, Inc. (the "Company," "Montrose" or "MEG") (NYSE: MEG) is on a mission to help protect the air we breathe, the water we drink, and the soil that feeds us, and aims to enhance environmental...

West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the BofA Securities Annual Healthcare Conference on...

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced financial and operational results for the first quarter ended March 31, 2025.

https://34lives.com/

In 10 years since its launch, the Edmond J. Safra Fellowship in Movement Disorders has provided care to an estimated 31,000 patients across 35 centers in four continentsThe world-renowned program has made significant...

Aspen Neuroscience has released 6-month data from the first three patients dosed in the ASPIRO Phase 1/2a trial of ANPD001, an investigational autologous dopaminergic neuronal precursor cell (DANPC) therapy being studied...

A new Medtronic-sponsored survey of women ages 30-50 reveals a significant gap in awareness and discussion around heart health among women and their mother-figures. Despite cardiovascular disease being the #1 killer of...

Imre signals a bold new era of client-focused growth with the appointment of Greg Voyles as Chief Growth Officer. This appointment highlights Imre's commitment to continued growth as a healthcare agency-of-record...

The impact of research conducted at Cincinnati Children's isn't limited to the childhood years.

Eurofins Viracor, a leading specialty diagnostics laboratory, is proud to announce a groundbreaking advancement in respiratory infection diagnostics with the launch of a new bronchoalveolar lavage (BAL) specimen type for...

Hanx Biopharmaceuticals Ltd. (HanxBio), a clinical-stage biotechnology company pioneering next-generation immunotherapies, highlighted its expanding oncology and autoimmune disease pipeline with five research poster...

Lipogems is proud to announce the completion of the ARISE I U.S. FDA IDE Study with the last patient's last visit successfully completed. This milestone marks the conclusion of a key phase in the advancement of...

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced that two poster presentations on investigational ND0612 in Parkinson's disease (PD) will be shared at the 30th World Congress on Parkinson's Disease and...

Abbott (NYSE: ABT) announced today the creation of the inaugural 'Abbott Dream Team.' The program will seek out talented soccer players from across the United States and give them a once-in-a-lifetime opportunity...

A new national survey conducted by Highland Electric Fleets finds that voters and parents strongly associate electric school buses with better student mental health, particularly for children with special needs or sensory...

Aspen Neuroscience scientists, led by Chief Scientific Officer Xiaokui Zhang, Ph.D., will present at the International Society for Gene & Cell Therapy (ISCT) Annual Meeting, held this week May 7-10 at the Ernest N....

CAMBRIDGE, Mass., May 7, 2025 /PRNewswire/ – Invaio Sciences, a leading bioplatform company founded by Flagship Pioneering and accelerating the transition to nature-positive agriculture, today announced the appointment of...

Cure, a premier healthcare innovation ecosystem headquartered in New York City, today announced  the two winning teams of the fifth annual XSeed Award, each set to receive a $250,000 grant. The XSeed Award is dedicated to...

CaliberMRI, an industry leader in standardizing Magnetic Resonance Imaging (MRI), announced that qCal-MR®, an integrated quality assurance (QA) software platform, now supports phantom scan analysis on more than 40 MRI...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that following the...

First Quarter 2025 Highlights: Net sales of $1.04 billion declined 3.5%, due primarily to an unfavorable impact of 3.2% from divested businesses, exited product lines and currency translation. Organic1 net sales decreased...

Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the second quarter ended March 31, 2025.

Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, today announced that LSU LCMC Health Cancer Center (the Cancer Center) has joined the Caris Precision Oncology...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that during a meeting of its Board of Directors held today, it decided a change in Directors as outlined below. The appointment...

Ajinomoto Co., Inc. (President: Shigeo Nakamura, Headquarters: Chuo-ku, Tokyo, hereinafter referred to as "Ajinomoto") has been conducting joint research* with RIBOMIC Inc. (President: Yoshikazu Nakamura, Headquarters:...

CStone Pharmaceuticals ("CStone", HKEX: 2616), an innovation-driven biopharmaceutical company focused on anti-cancer therapies, announced today that poster presentations of preclinical data of CS2011 (EGFR/HER3 bispecific...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and...

Adcentrx Therapeutics ("Adcentrx"), a clinical-stage biotechnology company redefining Antibody-Drug Conjugate (ADC) therapies for cancer treatment and other life-threatening diseases, today announced that the U.S. Food and...

MEXICO CITY, May 6, 2025 /PRNewswire/ - Apotex Inc. (referred to as "Apotex" or "the Company") today announced it has entered into an exclusive licensing agreement with Formosa Pharmaceuticals ("Formosa", 6838.TW), for...

Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced today that the company has entered into an exclusive licensing agreement with Apotex Inc. ("Apotex"), for exclusive rights in Mexico for the...

SHINE Technologies, a nuclear fusion company with a platform of medical isotope products, announced it has entered into a definitive agreement to acquire the SPECT business from Lantheus, a leading...

An innovation in managing post-surgical chest wall pain promises less reliance on opioids, fewer complications and faster recovery for patients. A cardiothoracic surgeon at the University of Colorado Anschutz Medical...

BayCare Health System today announced that Keri Eisenbeis, Chief of Staff and Chief Communications Officer, is stepping into an expanded role. Starting immediately, Eisenbeis will also oversee the not-for-profit health...

Tellihealth, formed through the merger of Accuhealth and Signallamp Health, proudly announces its new brand identity. This transformation reflects Tellihealth's commitment to delivering intelligent, personalized...

Plasmidsaurus, the company that sequences while you sleep, today announced the opening of its tenth global sequencing lab, located in Singapore's vibrant biomedical hub. The new site dramatically shortens turnaround...

Curai Health, a virtual primary care provider, today announced a partnership with Rula Health, a national behavioral healthcare provider group that delivers high-quality mental healthcare. This collaboration will provide...

PLANTATION, Fla., May 6, 2025 /PRNewswire/ - Akumin, a leader in managed radiology and oncology services, is pleased to announce the appointment of Dr. Nasir Siddiqui as Chief Medical Officer (CMO).

PRM Pharma, LLC today announced the U.S. Food and Drug Administration (FDA) approval of HemiClor (12.5 mg chlorthalidone) tablets for the treatment of hypertension in adults, to lower blood pressure.

Researchers at Children's Hospital of Philadelphia (CHOP) highlighted the success of anaplastic lymphoma kinase (ALK) inhibition therapy in treating hereditary neuroblastoma, a rare subset of a common childhood cancer....

According to a new Maternal Health in the Workplace report from Carrot Fertility, business leaders and working mothers across America agree the country is undergoing a maternal health crisis. Carrot, the?leading global...

Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, is pleased to announce its participation in the 45th...

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the launch of ConnectING with Carnie™, a multimedia awareness campaign in partnership with Grammy-nominated singer-songwriter and mental health advocate, Carnie...

Apnimed, Inc., a pharmaceutical company building the industry-leading portfolio of first-in-class oral drugs that address the root causes of obstructive sleep apnea (OSA) and other sleep-related breathing diseases, today...

AbbVie (NYSE: ABBV) will participate in the Bank of America Securities Healthcare Conference on Wednesday, May 14, 2025. Management will participate in a fireside chat at 12:00 p.m. Central time.

Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced financial results for the three months ended March 31, 2025, and highlighted recent corporate...

Trailhead Biosystems Inc. (www.trailbio.com), a biotechnology company advancing human cell innovation, has secured $20 million in financing. Trailhead specializes in precisely differentiating induced pluripotent stem cells...

Ascidian Therapeutics, a biotechnology company seeking to treat human diseases by rewriting RNA, today announced the formation of its Scientific Advisory Board (SAB). These globally recognized leaders in RNA biology and...

"The results of the first quarter of 2025 once again demonstrate our continuous operational and financial progress as we are executing the third and last year of our current strategic plan," said Helen Giza, Chief...

Conference call and webcast to take place on Wednesday, May 14, 2025, at 4:30 p.m. ET

Safe Life, a leading provider of life-saving solutions with operations across Europe and North America, announces the acquisition of resQshock (https://www.resqshock.ch), a Swiss company specialized in sales and service of...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced it has entered into an...

Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2025 financial results.